Skala is a platform designed to help founders and entrepreneurs launch, manage, and grow companies globally. It provides company formation services (including US, Panama, BVI, and UAE entities), legal and IP management, customizable document templates, and access to corporate services such as accounting, payroll, and banking. Skala also offers AI-driven tools and legal support specifically tailored for startups and businesses working in AI, crypto, SaaS, GameDev, and the creator economy.
SKALA 2025 estimated revenue: $3.4M ARR. 31 employees. Industry: Venture Capital. Founded 2018. HQ: Indonesia Updated Aug 10, 2026.
Microsoft Research's Skala 1.1 deep-learning DFT approach enhances molecular simulation accuracy and accessibility, integrating into key scientific software.
AMDs Helios rackskaliga plattform med MI455X GPU:er och EPYC Venice landar på Azure i takt med att Microsoft expanderar virtuella maskiner och Pensando DPU:er.
Human pluripotent stem cell (hPSC)-derived cardiomyocytes provide a promising regenerative cell therapy for cardiovascular patients and an important model system to accelerate drug discovery. However, cost-effective and time-efficient platforms must be developed to evaluate the quality of hPSC-derived cardiomyocytes during biomanufacturing. Here, we develop a non-invasive label-free live cell imaging platform to predict the efficiency of hPSC differentiation into cardiomyocytes. Autofluorescence imaging of metabolic co-enzymes is performed under varying differentiation conditions (cell density, concentration of Wnt signaling activator) across five hPSC lines. Live cell autofluorescence imaging and multivariate classification models provide high accuracy to separate low (< 50%) and high (≥ 50%) differentiation efficiency groups (quantified by cTnT expression on day 12) within 1 day after initiating differentiation (area under the receiver operating characteristic curve, 0.91). This non-invasive and label-free method could be used to avoid batch-to-batch and line-to-line variability in cell manufacturing from hPSCs. Differentiation of hPSCs to cardiomyocytes suffers from high variability. Here the authors report a label-free live cell imaging platform based on autofluorescence imaging to enable the prediction of cardiomyocyte differentiation efficiency from hPSCs.
On May 7, SK AX announced that it will expand its employment-linked artificial intelligence (AI) training program, SKALA, beyond the Seoul metropolita
Visit Skala's official website for product details and getting started.
Comprehensive guides and resources for using Skala effectively.
Insights and articles on entrepreneurship, company formation, and legal topics.
Detailed pricing plans for the various services and features offered by Skala.